Issuer directory · Biotechnology

Biotechnology: private offerings on SEC Form D.

832 issuers in this group filed a Form D since 2024, reported at least $1 million sold, and either raised from ten or more investors or amended the notice at least once. Ranked by the amount reported sold on the newest notice, 100 to a page. The platform column names the AltStreet-reviewed platform an issuer belongs to; "direct" means none is on record.

IssuerReported soldInvestorsExemptionNewest noticeFilingsPlatform
Neuralink Corp.$649.0M49506(b)Jun 12, 20251direct
Denali Therapeutics Inc.$499.7M11506(b)Mar 1, 20241direct
Neumora Therapeutics, Inc.$474.4M124506(b)Jan 3, 20231direct
Treeline Biosciences, Inc.$421.8M43506(b)Oct 17, 20241direct
Avidity Biosciences, Inc.$400.2M45506(b)Mar 19, 20241direct
Avenzo Therapeutics, Inc.$385.9M22506(b)Nov 20, 20243direct
Kriya Therapeutics, Inc.$361.8M29506(b)Jul 27, 20232direct
Areteia Therapeutics, Inc.$360.0M16506(b)Feb 21, 20253direct
LISATA THERAPEUTICS, INC.$351.9M20506(b)Oct 2, 20261direct
Eikon Therapeutics, Inc.$350.7M27506(b)Feb 28, 20251direct
Crinetics Pharmaceuticals, Inc.$350.0M36506(b)Mar 11, 20241direct
Sensei Biotherapeutics, Inc.$348.9M104506(b)Mar 4, 20261direct
Arsenal Biosciences, Inc.$325.4M26506(b)Sep 4, 20241direct
GRAIL, Inc.$325.0M17506(b)Nov 7, 20251direct
Galecto, Inc.$285.0M48506(b)Nov 21, 20251direct
Pathos AI, Inc.$283.0M11506(b)May 1, 20251direct
Entera Bio Ltd.$275.0M53506(b)Aug 12, 20261direct
Cardurion Pharmaceuticals, Inc.$260.4M19506(b)Jul 24, 20241direct
RECODE THERAPEUTICS, INC.$259.8M28506(b)Sep 28, 20234direct
Rhodenergy An Environmental Co Corp$250.0M0506(c)Jan 15, 20261direct
Zai Lab Ltd$249.9M25506(b)Nov 9, 20261direct
Cidara Therapeutics, Inc.$240.0M7506(b)May 6, 20241direct
Summit Therapeutics Inc.$235.0M17506(b)Sep 26, 20241direct
Seaport Therapeutics, Inc.$225.9M33506(b)Oct 31, 20241direct
Genesis Therapeutics, Inc.$224.0M50506(b)Aug 25, 20231direct
AdvanCell, Inc.$218.3M41506(b)Jul 16, 20261direct
Metsera, Inc.$215.0M38506(b)Nov 20, 20241direct
Odyssey Therapeutics, Inc.$214.0M55506(b)Dec 4, 20251direct
Gossamer Bio, Inc.$212.1M70506(b)Aug 7, 20231direct
Aeglea BioTherapeutics, Inc.$210.0M41506(b)Jul 6, 20231direct
Zenas BioPharma, Inc.$200.1M26506(b)May 14, 20241direct
ADARx Pharmaceuticals, Inc.$200.0M28506(b)Aug 10, 20231direct
IMMUNIC, INC.$200.0M43506(b)Mar 4, 20261direct
TheRas, Inc.$200.0M15506(b)May 15, 20241direct
Tyra Biosciences, Inc.$200.0M21506(b)Feb 13, 20241direct
LUMICELL, INC.$198.1M64506(b)May 6, 20251direct
BioAge Labs, Inc.$194.4M32506(b)Feb 13, 20241direct
Surrozen, Inc./DE$193.0M18506(b)Apr 19, 20241direct
Avalyn Pharma Inc.$189.2M26506(b)Oct 10, 20231direct
MapLight Therapeutics, Inc.$188.2M19506(b)Jul 28, 20251direct
Tectonic Therapeutic, Inc.$185.0M29506(b)Feb 14, 20251direct
Tune Therapeutics, Inc.$182.4M39506(b)Jan 24, 20251direct
Epicrispr Biotechnologies, Inc.$176.8M47506(b)Aug 26, 20261direct
SAB Biotherapeutics, Inc.$175.0M17506(b)Aug 5, 20251direct
Aktis Oncology, Inc.$175.0M39506(b)Oct 2, 20241direct
Ollin Biosciences, Inc.$156.2M32506(b)Jun 24, 20261direct
Kyverna Therapeutics, Inc.$152.0M24506(b)Nov 7, 20231direct
Kura Oncology, Inc.$150.0M10506(b)Feb 5, 20241direct
Cellanome, Inc.$150.0M20506(b)Jan 29, 20241direct
Carmot Therapeutics Inc.$150.0M25506(b)Jun 6, 20231direct
RAPT Therapeutics, Inc.$150.0M20506(b)Jan 3, 20251direct
Taysha Gene Therapies, Inc.$150.0M42506(b)Aug 25, 20231direct
Vascular Perfusion Solutions, Inc.$147.0M21506(b)May 30, 20251direct
Syncromune, Inc.$144.8M77506(b)May 11, 20263direct
Veronica Holdings, LLC$142.3M72506(b)Mar 3, 20251direct
NGM Bio Holdings, Inc.$142.0M26506(b)Mar 27, 20262direct
ImmPACT Bio USA Inc.$139.9M15506(b)Apr 2, 20242direct
Impulse Dynamics plc$136.5M11506(b)May 20, 20241direct
Chroma Medicine, Inc.$135.0M21506(b)Sep 1, 20232direct
Electra Therapeutics, Inc.$134.2M19506(b)Oct 30, 20251direct
Endeavor Biomedicines, Inc.$132.6M32506(b)May 3, 20241direct
Jasper Therapeutics, Inc.$132.0M40506(b)Aug 5, 20261direct
Avalo Therapeutics, Inc.$130.6M25506(b)Apr 9, 20241direct
Cartesian Therapeutics, Inc.$130.0M22506(b)Jul 17, 20241direct
Celcuity Inc.$130.0M2506(b)Sep 23, 20256direct
Organogenesis Holdings Inc.$130.0M2506(b)Nov 27, 20241direct
NewLimit, Inc.$129.8M38506(b)May 15, 20251direct
ALUMIS INC.$129.5M24506(b)Mar 11, 20241direct
Ensoma, Inc.$129.0M22506(b)May 23, 20232direct
Adverum Biotechnologies, Inc.$127.8M20506(b)Feb 21, 20241direct
ALZHEON, INC.$126.3M76506(c)Feb 10, 20253direct
Scorpion Therapeutics, Inc.$125.7M38506(b)Jul 16, 20241direct
SonoThera, Inc.$125.5M22506(c)Jun 30, 20261direct
Oric Pharmaceuticals, Inc.$125.0M15506(b)Jun 6, 20251direct
BigHat Biosciences, Inc.$124.1M40506(b)Apr 28, 20252direct
Cambrian BioPharma Inc$123.8M80506(c)Jul 15, 20261direct
Lyndra Therapeutics, Inc.$122.7M16506(b)Dec 29, 20231direct
Solstice Oncology, Inc.$121.3M8506(b)Mar 9, 20261direct
Abcuro, Inc.$120.1M21506(b)Aug 25, 20231direct
Eliem Therapeutics, Inc.$120.0M8506(b)Jul 2, 20241direct
NEURONA THERAPEUTICS, INC$120.0M35506(b)Feb 13, 20241direct
VEDANTA BIOSCIENCES, INC.$118.5M25506(b)Aug 5, 20242direct
ILIAD BIOTECHNOLOGIES, INC.$115.5M36506(b)Feb 20, 20261direct
Quince Therapeutics, Inc.$114.7M27506(b)Jun 11, 20261direct
Zura Bio Ltd$112.5M19506(b)May 6, 20241direct
Elektrofi, Inc.$112.3M21506(b)Oct 15, 20242direct
Rakuten Medical, Inc.$111.5M26506(b)Apr 13, 20261direct
Zephyr AI, Inc.$111.4M30506(b)Mar 13, 20241direct
Strand Therapeutics Inc.$108.1M10506(b)Mar 17, 20261direct
Vizgen, Inc.$107.6M61506(b)Oct 22, 20241direct
Jnana Therapeutics Inc.$107.0M8506(b)Jan 26, 20242direct
Lycia Therapeutics, Inc.$106.6M16506(b)May 23, 20241direct
Aligos Therapeutics, Inc.$105.0M12506(b)Feb 28, 20251direct
Iambic Therapeutics, Inc.$103.2M18506(b)Oct 12, 20231direct
Autobahn Therapeutics, Inc.$100.8M22506(b)Aug 1, 20241direct
Harpoon Therapeutics, Inc.$100.2M18506(b)Oct 31, 20231direct
Aadi Bioscience, Inc.$100.0M17506(b)Mar 18, 20251direct
Boundless Bio, Inc.$100.0M26506(b)Aug 15, 20231direct
Applied Therapeutics, Inc.$100.0M31506(b)Mar 13, 20241direct
Galvanize Therapeutics, Inc.$96.1M28506(b)Sep 11, 20251direct

Source: SEC EDGAR Form D and D/A filings. A Form D is a notice of an exempt offering; the SEC does not review or approve the offering. Reported figures are the issuer's own. Other groups: the full directory.